HC-030031
99%
- Product Code: 110642
CAS:
349085-38-7
| Molecular Weight: | 355.39 g./mol | Molecular Formula: | C₁₈H₂₁N₅O₃ |
|---|---|---|---|
| EC Number: | MDL Number: | MFCD02007349 | |
| Melting Point: | Boiling Point: | ||
| Density: | Storage Condition: | room temperature, dry |
Product Description:
HC-030031 is primarily used in research settings as a selective antagonist for the TRPA1 receptor, which is involved in pain sensation and inflammatory responses. It is widely utilized in studies to investigate the role of TRPA1 in various physiological and pathological conditions, such as chronic pain, neuropathic pain, and inflammatory diseases. Researchers employ HC-030031 to block TRPA1 channels, helping to understand their contribution to pain signaling and to explore potential therapeutic targets for pain management. Additionally, it is used in preclinical studies to evaluate the efficacy of TRPA1 inhibition in reducing hypersensitivity and inflammation in animal models. Its application extends to studying the mechanisms of sensory transduction and the development of novel analgesics.
Product Specification:
| Test | Specification |
|---|---|
| Appearance | Solid |
| Purity (%) | 98.5-100 |
| Infrared Spectrum | Conforms To Structure |
Sizes / Availability / Pricing:
| Size (g) | Availability | Price | Quantity |
|---|---|---|---|
| 0.025 | 10-20 days | €86.01 |
+
-
|
| 0.050 | 10-20 days | €139.30 |
+
-
|
| 0.100 | 10-20 days | €224.25 |
+
-
|
| 1.000 | 10-20 days | €817.31 |
+
-
|
HC-030031
HC-030031 is primarily used in research settings as a selective antagonist for the TRPA1 receptor, which is involved in pain sensation and inflammatory responses. It is widely utilized in studies to investigate the role of TRPA1 in various physiological and pathological conditions, such as chronic pain, neuropathic pain, and inflammatory diseases. Researchers employ HC-030031 to block TRPA1 channels, helping to understand their contribution to pain signaling and to explore potential therapeutic targets for pain management. Additionally, it is used in preclinical studies to evaluate the efficacy of TRPA1 inhibition in reducing hypersensitivity and inflammation in animal models. Its application extends to studying the mechanisms of sensory transduction and the development of novel analgesics.
| Mechanism | - |
| Appearance | - |
| Longevity | - |
| Strength | - |
| Storage | - |
| Shelf Life | - |
| Allergen(s) | - |
| Dosage (Range) | - |
| Recommended Dosage | - |
| Dosage (Per Day) | - |
| Recommended Dosage (Per Day) | - |
| Mix Method | - |
| Heat Resistance | - |
| Stable in pH range | - |
| Solubility | - |
| Product Types | - |
| INCI | - |
Cart
No products
Subtotal:
€0.00
€0.00
Total :